Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03276780 · ClinicalTrials.gov registry record · Phase 4
Nicotine Replacement Therapy (NRT) Sampling and Selection to Increase Medication Adherence
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT03276780 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 80 participants.
The verdict
NCT03276780, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
To determine the preliminary impact on Nicotine Replacement Therapy (NRT)adherence and examine the underlying mechanisms of action associated with adherence.
Interventions
- BEHAVIORAL Counseling
- DRUG combination NRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-05-03 |
| Est. Completion | 2020-10-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03276780
The ClinicalTrials.gov registry entry for NCT03276780 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Counseling is the first listed.
NCT03276780 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03276780 about?
NCT03276780 is a clinical study titled "Nicotine Replacement Therapy (NRT) Sampling and Selection to Increase Medication Adherence". To determine the preliminary impact on Nicotine Replacement Therapy (NRT)adherence and examine the underlying mechanisms of action associated with adherence.
What is the current status of trial NCT03276780?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2018-05-03. Estimated completion is 2020-10-31.
What interventions are being tested in trial NCT03276780?
The interventions under investigation include: Counseling (BEHAVIORAL), combination NRT (DRUG).
Who is sponsoring clinical trial NCT03276780?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.